-- Second continuous year of gross profit
growth --
-- Total SG&A expenses declined to the
lowest levels since 2019 --
-- GoodWheatTM now in more than 3,500 stores
with better-for-you pasta, pancake/waffle mixes and mac &
cheese --
Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and
marketer of innovative, plant-based health and wellness products,
today released its financial and business results for the fourth
quarter and full year of 2023.
“We are now at the halfway point of Project Greenfield, our
three-year strategic plan to unlock the company’s potential and
provide a path to profitability, and the results of this focus are
unmistakable,” said Stan Jacot, president and CEO. “Arcadia has
significantly improved quality of revenues and has now delivered
two straight years of gross profit growth for the first time in its
history. SG&A expenses have declined for two straight years and
are at their lowest level since 2019.
“The foundation we have laid over the past two years provides
optimism for even stronger results in 2024. GoodWheatTM is now in
three categories with pasta, pancakes and mac & cheese, and
garnering national attention. Zola® coconut water is leveraging
innovation to expand distribution and is anticipating double-digit
growth in 2024. We have right sized the organization and
streamlined our cost structure in order to extend our runway. And
finally, we remain focused on adjacent acquisitions as well as
monetizing our IP,” Jacot said.
2023 Key Operating and Business Highlights
- GoodWheat Expands Into Two New Categories
with Better-For-You Pancake and Waffle Mixes, Single-Serve
QuikcakesTM and Mac & Cheese. Building on its success
with GoodWheat high-fiber pasta, Arcadia launched two new product
categories in 2023: pancake/waffle mixes and mac & cheese.
Launched in Q3, Arcadia’s pancake and waffle mixes are made with
simple ingredients and its proprietary GoodWheat flour, delivering
the same delicious taste and texture of regular pancakes with 8-11
times the fiber and 5-7 grams of protein per serving. GoodWheat
single-serve Quikcakes, in Buttermilk, Chocolate Chocolate Chip and
Confetti flavors, are available nationwide on Amazon, and both
Quikcakes and Multi-Serve Pancake & Waffle Mixes, available in
Buttermilk, Chocolate Chocolate Chip and Apple Cinnamon flavors,
began shipping to retailers in August. Arcadia expanded to a third
category with the launch of GoodWheat Mac & Cheese in Q4, a
family household staple representing more than $1.1 billion in
sales. Better-for-you brands make up nearly 20% of the category and
are growing faster than traditional brands. GoodWheat Mac &
Cheese packs in the most fiber of any brand in the category, with
four times more fiber than the leading brand, as well as 12 grams
of protein. One serving of GoodWheat Mac & Cheese has the same
fiber as two servings of oatmeal or two and a half servings of
broccoli. Available in three varieties – Classic Cheddar, White
Cheddar and Three Cheese – GoodWheat Mac & Cheese began
shipping to retailers in November 2023, and launched on Amazon in
February 2024.
- GoodWheat Pasta Certified as “Heart
Healthy” by American Heart Association (AHA). GoodWheat
pasta received the AHA’s Heart-Check certification for all five
varieties of its single ingredient noodles. With its high fiber,
lower sodium and zero saturated fat, GoodWheat meets the AHA’s
stringent standards for a heart-healthy pasta and provides
consumers with a better-for-you option that delivers superior
nutrition with the taste and texture of traditional pasta.
- Arcadia Streamlines Operations by Exiting
CBD Body Care Brands. As part of its strategy to focus
resources on high-opportunity, scalable businesses, Arcadia
discontinued its two remaining Body Care brands ProVaultTM and
SoulSpringTM in order to concentrate on the more promising
GoodWheat and Zola brands. Streamlined operations and
organizational changes resulted in operating expense savings of $2
million in 2023 and $3 million to $4 million annually going
forward.
- Arcadia Explores Strategic Opportunities
with Lake Street Capital Markets. Arcadia initiated a
strategic review process in mid-2023 to explore a range of
potential transactions and opportunities focused on maximizing the
GoodWheat value proposition and driving long-term shareholder
value. As part of this process, the company is exploring strategic
options that may include potential acquisition, company sale,
merger, business combination, asset sale, joint venture, licensing
arrangement, capital raise or other strategic transactions.
Recent Highlights
- Zola Coconut Water Introduces Two New
Flavors to Energize Sales. Arcadia has focused on innovation
in Zola coconut water with the introduction of two new flavors –
pineapple and lime – to add to its original, extra pulp and
espresso flavors. Pineapple is the number one coconut water flavor,
and Lime is the number one flavor in sparkling water, and both
flavors are 100% natural, no sugar added and non-GMO. Launched in
the first quarter of 2024, these new flavors are available in 16.9
oz resealable containers and will be placed in new distribution in
Q2.
- GoodWheat Pasta and Pancake Mixes Receive
Accolades From Trusted, Independent Testing Outlets.
Following GoodWheat pasta’s 2023 recognition from the American
Heart Association’s Heart-Check certification and its selection as
“Best New Product” by the Retail Dietitians Business Alliance,
GoodWheat pasta and pancake mixes received additional accolades
from trusted outlets in the first quarter of 2024. Better Homes and
Gardens, with 13 million followers across social platforms,
recognized GoodWheat pasta in the New Basics category as the “Best
Stealthy Healthy Pasta,” with the same flavor as regular pasta but
four times the fiber. And Eat This, Not That, a website which has 7
million unique views per month, awarded GoodWheat Quikcakes
recognition in two different categories in January: “Best
Store-Bought, High-Protein Desserts” and “Best Store-Bought
High-Fiber Snacks.”
Arcadia Biosciences, Inc.
Financial Snapshot (Unaudited) ($ in thousands)
Three months ended Dec
31
Twelve months ended Dec
31
2023
2022
Favorable/
(Unfavorable)
2023
2022
Favorable/
(Unfavorable)
$
%
$
%
Total Revenues
1,170
744
426
57
%
5,330
7,418
(2,088
)
(28
%)
Total Operating Expenses
4,534
5,402
868
16
%
19,268
21,425
2,157
10
%
Loss From Continuing Operations
(3,364
)
(4,658
)
1,294
28
%
(13,938
)
(14,007
)
69
0
%
Net Loss Attributable to Common
Stockholders
(2,853
)
(4,244
)
1,391
33
%
(13,981
)
(15,376
)
1,395
9
%
Certain previously reported financial information has been
reclassified to conform to the current year presentation.
Reclassifications are related to the presentation of the financial
results of our former body care brands as discontinued operations.
The financial information above and narrative that follows relate
to continuing operations unless stated otherwise.
More detailed financial statements are included in the Form 10-K
filed today, available in the Investors section of the company’s
website under SEC Filings.
Revenues
Revenues in the fourth quarter of 2023 increased 57% to $1.2
million compared to the same period in 2022 driven by higher
GoodWheat and GLA revenues.
Revenues decreased $2.1 million during 2023 compared 2022.
Revenues during 2022 included approximately $1.8 million in sales
of GoodWheat grain as well as $0.9 million in one-time license
revenue related to the sale of Verdeca.
Operating Expenses
Operating expenses decreased $868,000 during the fourth quarter
of 2023 compared to the same period in 2022 primarily driven by a
decrease in cost of revenues and selling, general and
administrative (SG&A) expenses in 2023. Cost of revenues in the
fourth quarter of 2022 included higher inventory write downs. The
decrease in SG&A was primarily related to lower employee costs
in 2023.
Operating expenses decreased $2.1 million during 2023 compared
to 2022 primarily driven by a decrease in cost of revenues and
SG&A. Cost of revenues in 2022 included grain sold at cost and
higher inventory write-downs. The decrease in SG&A was
primarily related to lower employee costs in 2023.
Net Loss Attributable to Common Stockholders
Net loss attributable to common stockholders for the fourth
quarter of 2023 was $2.8 million, or $2.10 per share, a $1.4
million improvement from the $4.2 million, or $6.31 per share, net
loss for the fourth quarter of 2022. The improvement in net loss
attributable to common stockholders for the fourth quarter of 2023
compared to the same period in 2022 was primarily driven by the
reduction in operating expenses.
Net loss attributable to common stockholders for 2023 was $14.0
million, or $11.30 per share, a $1.4 million improvement from the
$15.4 million, or $25.65 per share, net loss for 2022. The
improvement in net loss attributable to common stockholders for
2023 compared to 2022 was primarily driven by the reduction in
operating expenses. The impact of the March 2023 financing had a
minimal effect during 2023 as a $6.1 million valuation loss was
largely offset by a non-cash gain of $6.5 million related to the
change in the fair value of the common stock warrant and option
liabilities compared to a non-cash gain of $3.2 million during
2022. Additionally, 2023 included a net loss from the discontinued
body care brands of $821,000 compared to $4.8 million during
2022.
Conference Call and Webcast
The company has scheduled a conference call for 4:30 p.m.
Eastern time (1:30 p.m. Pacific time) today, March 28, to discuss
fourth-quarter and year-end results and the year’s key strategic
achievements. Interested participants can join the conference call
using the following options:
- An audio-only webcast of the conference call will be available
in the Investors section of Arcadia’s website.
- To join the live call, please register here, and a dial-in
number and unique PIN will be provided.
Following completion of the call, a recorded replay will be
available on the company’s investor website.
About Arcadia Biosciences, Inc.
Since 2002, Arcadia Biosciences (Nasdaq: RKDA) has been
innovating crops to provide high-value, healthy ingredients to meet
consumer demands for healthier choices. With its roots in
agricultural innovation, Arcadia cultivates next-generation
wellness products that make every body feel good. The company’s
food and beverage products include GoodWheat™ pasta, pancake mixes
and mac & cheese and Zola® coconut water. For more information,
visit www.arcadiabio.com.
Safe Harbor Statement
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995
about the company and its products, including statements relating
to the company’s growth, cash position, operating costs, financial
performance, commercialization of products and review of strategic
transactions and their impact on shareholder value. Forward-looking
statements are subject to risks and uncertainties that could cause
actual results to differ materially, and reported results should
not be considered as an indication of future performance. These
risks and uncertainties include, but are not limited to, the risks
set forth in filings that the company makes with the Securities and
Exchange Commission from time to time, including in Arcadia’s
Annual Report on Form 10-K for the year ended December 31, 2023 and
other filings. These forward-looking statements speak only as of
the date hereof, and Arcadia Biosciences, Inc. disclaims any
obligation to update these forward-looking statements.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240328469268/en/
T.J. Schaefer ir@arcadiabio.com
Arcadia Biosciences (NASDAQ:RKDA)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Arcadia Biosciences (NASDAQ:RKDA)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025